Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 36, 2012 - Issue 5
360
Views
18
CrossRef citations to date
0
Altmetric
Original Article

A Single Nucleotide Polymorphism in the HBBP1 Gene in the Human β-Globin Locus is Associated with a Mild β-Thalassemia Disease Phenotype

, , , , , , , & show all
Pages 433-445 | Received 05 May 2012, Accepted 19 Jun 2012, Published online: 19 Sep 2012

REFERENCES

  • Patrinos GP, Antonarakis SE. Human hemoglobin. In: Speicher M, Antonarakis SE, Motulsky A, Eds. Human Genetics: Problems and Approaches, 4th ed. Heidelberg: Springer. 2010:365–401.
  • Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537–D541 (http://globin.cse.psu.edu).
  • Giardine B, van Baal S, Kaimakis P, et al. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat. 2007;28(2):206 (http://globin.cse.psu.edu).
  • Uda M, Galanello R, Sanna S, . Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of β-thalassemia. Proc Natl Acad Sci USA. 2008;105(5):1620–1625.
  • Lettre G, Sankaran VG, Bezerra MA, . DNA polymorphisms at the BCL11A, HBS1L-MYB, and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA. 2008;105(33):11869–11874.
  • Sankaran VG, Menne TF, Xu J, . Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science. 2008;322(5909):1839–1842.
  • Borg J, Papadopoulos P, Georgitsi M, . Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet. 2010;42(9):801–805.
  • Satta S, Perseu L, Maccioni L, Giagu N, Galanello R. Delayed fetal hemoglobin switching in subjects with KLF1 gene mutation. Blood Cells Mol Dis. 2012;48(1):22–24.
  • Gallienne AE, Dréau HM, Schuh A, Old JM, Henderson S. Ten novel mutations in the erythroid transcription factor KLF1 gene associated with increased fetal hemoglobin levels in adults. Haematologica. 2012;97(3):340–343.
  • Thein SL, Menzel S, Peng X, . Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc Natl Acad Sci USA. 2007;104(27):11346–11351.
  • Galarneau G, Palmer CD, Sankaran VG, Orkin SH, Hirschhorn JN, Lettre G. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet. 2010;42(12):1049–1051.
  • Farrell JJ, Sherva RM, Chen ZY, . A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with Hb F expression. Blood. 2011;117(18):4935–4945.
  • Gilman JG, Huisman THJ. DNA sequence variation associated with elevated fetal Gγ globin production. Blood. 1985;66(4):783–787.
  • Garner C, Tatu T, Reittie JE, . Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood. 2000;95(1):342–346.
  • Nuinoon M, Makarasara W, Mushiroda T, . A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/Hemoglobin E. Hum Genet. 2010;127(3):303–314.
  • Papachatzopoulou A, Kourakli A, Makropoulou P, . Genotypic heterogeneity and correlation to intergenic haplotype within high Hb F β-thalassemia intermedia. Eur J Haematol. 2006;76(4):322–330.
  • Papachatzopoulou A, Kaimakis P, Pourfarzad F, . Increased γ-globin gene expression in β-thalassemia intermedia patients correlates with a mutation in 3′HS1. Am J Hematol. 2007;82(11):1005–1009.
  • Papachatzopoulou A, Kourakli A, Stavrou EF, . Region-specific genetic heterogeneity of HBB mutation distribution in South-Western Greece. Hemoglobin. 2010;34(4):333–342.
  • Patrinos GP, van Baal S, Petersen MB, Papadakis MN. The Hellenic National Mutation Database: a prototype database for mutations leading to inherited disorders in the Hellenic population. Hum Mutat. 2005;25(4):327–333.
  • Ma Q, Abel K, Sripichai O, . β-Globin gene cluster polymorphisms are strongly associated with severity of Hb E/β0-thalassemia. Clin Genet. 2007;72(6):497–505.
  • Sankaran VG, Xu J, Byron R, . A functional element necessary for fetal hemoglobin silencing. N Engl J Med. 2011;365(9):807–814.
  • Sherva R, Sripichai O, Abel K, . Genetic modifiers of Hb E/β0 thalassemia identified by a two-stage genome-wide association study. BMC Med Genet. 2010;11:51.
  • Dover GJ, Smith KD, Chang YC, . Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood. 1992;80(3):816–824.
  • Close J, Game L, Clark B, Bergounioux J, Gerovassili A, Thein SL. Genome annotation of a 1.5 Mb region of human chromosome 6q23 encompassing a quantitative trait locus for fetal hemoglobin expression in adults. BMC Genomics. 2004;5(1):33.
  • Ma Q, Wyszynski DF, Farrell JJ, . Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. Pharmacogenomics J. 2007;7(6):386–394.
  • Borg J, Phylactides M, Bartsakoulia M, . KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients. Pharmacogenomics. 2012; (in press).
  • Calzolari R, McMorrow T, Yannoutsos N, Langeveld A, Grosveld F. Deletion of a region that is a candidate for the difference between the deletion forms of hereditary persistence of fetal hemoglobin and δβ-thalassemia affects β- but not γ-globin gene expression. EMBO J. 1999;18(4):949–958.
  • Chakalova L, Osborne CS, Dai YF, . The Corfu δβ thalassemia deletion disrupts γ-globin gene silencing and reveals post-transcriptional regulation of Hb F expression. Blood. 2005;105(5):2154–2160.
  • Joly P, Lacan P, Garcia C, Couprie N, Francina A. Identification and molecular characterization of four new large deletions in the β-globin gene cluster. Blood Cells Mol Dis. 2009;43(1):53–57.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.